Your browser doesn't support javascript.
loading
Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.
Kapoor, Avnish; Yao, Wantong; Ying, Haoqiang; Hua, Sujun; Liewen, Alison; Wang, Qiuyun; Zhong, Yi; Wu, Chang-Jiun; Sadanandam, Anguraj; Hu, Baoli; Chang, Qing; Chu, Gerald C; Al-Khalil, Ramsey; Jiang, Shan; Xia, Hongai; Fletcher-Sananikone, Eliot; Lim, Carol; Horwitz, Gillian I; Viale, Andrea; Pettazzoni, Piergiorgio; Sanchez, Nora; Wang, Huamin; Protopopov, Alexei; Zhang, Jianhua; Heffernan, Timothy; Johnson, Randy L; Chin, Lynda; Wang, Y Alan; Draetta, Giulio; DePinho, Ronald A.
Affiliation
  • Kapoor A; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Yao W; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Ying H; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Hua S; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Liewen A; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Wang Q; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Zhong Y; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Wu CJ; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Sadanandam A; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Hu B; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Chang Q; The Institute of Cancer Research, 15 Cotswold Road, Belmont, Sutton, Surrey, SM2 5NG, U.K.
  • Chu GC; Swiss Institute for Experimental Cancer Research (ISREC), The Swiss Federal Institute of Technology Lausanne (EPFL), Station 19, CH-1015 Lausanne, Switzerland.
  • Al-Khalil R; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Jiang S; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Xia H; Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
  • Fletcher-Sananikone E; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Lim C; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Horwitz GI; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Viale A; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Pettazzoni P; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Sanchez N; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Wang H; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Protopopov A; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Zhang J; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Heffernan T; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Johnson RL; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Chin L; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Wang YA; Department of Pathology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • Draetta G; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
  • DePinho RA; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Cell ; 158(1): 185-197, 2014 Jul 03.
Article in En | MEDLINE | ID: mdl-24954535
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Phosphoproteins / Adenocarcinoma / Proto-Oncogene Proteins p21(ras) / Carcinoma, Pancreatic Ductal / Adaptor Proteins, Signal Transducing Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cell Year: 2014 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Phosphoproteins / Adenocarcinoma / Proto-Oncogene Proteins p21(ras) / Carcinoma, Pancreatic Ductal / Adaptor Proteins, Signal Transducing Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cell Year: 2014 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos